Clinical Trial Update: Minocycline in Patients With Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a Phase 1/Phase 2 trial evaluating minocycline in patients with Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Huntington's Disease | Phase 1, Phase 2 | Status: COMPLETED